| Enrolling By Invitation | A Study of Outcomes Following Bio-Reinforced Canaloplasty in Eyes With Open-Angle Glaucoma NCT07520175 | Iantrek, Inc. | — |
| Recruiting | Quality of Life After Glaucoma Surgery: Evaluating the Patient Perspective Across Surgical Options NCT07303257 | Hospices Civils de Lyon | — |
| Recruiting | Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use NCT07217678 | University of Miami | Phase 4 |
| Recruiting | Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma NCT07228221 | Jonathon Myers | Phase 4 |
| Recruiting | 24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients NCT07325240 | Mayo Clinic | Phase 4 |
| Active Not Recruiting | Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction NCT07082816 | Alcon Research | Phase 3 |
| Active Not Recruiting | This Follow-up Extension Study is Aimed to Monitor the Long-term IOP-lowering Performance/Efficacy and Safety NCT07081347 | Sanoculis Ltd | N/A |
| Recruiting | Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost NCT06883123 | Prairie Eye Center | Phase 4 |
| Recruiting | Vitamin Mix (B6, B9, B12, And Choline) For Glaucoma Patients NCT06885827 | Karolinska Institutet | N/A |
| Recruiting | Efficacy of Surgical Systems in Combination With Phacoemulsification: a Retrospective Analysis NCT06953349 | Barnet Dulaney Perkins Eye Centers | — |
| Not Yet Recruiting | MIMS® Retrospective Chart Review NCT06614218 | Sanoculis Ltd | — |
| Completed | Efficacy of Selective Laser Trabeculoplasty Targeting Nasal Versus Inferior 180-degree NCT06851546 | Mayo Clinic | N/A |
| Recruiting | A Study Investigating Oral Semaglutide in People with Open-Angle Glaucoma NCT06792422 | Glostrup University Hospital, Copenhagen | Phase 4 |
| Recruiting | A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China NCT06666855 | Santen Pharmaceutical Co., Ltd. | Phase 3 |
| Completed | Next Generation Rocklatan NCT06441643 | Alcon Research | Phase 2 |
| Not Yet Recruiting | Efficacy of NSAID vs. Steroid-NSAID Combo Post-Selective Laser Trabeculoplasty: Phase 4, Single-Center RCT NCT06498440 | St. Joseph's Healthcare Hamilton | Phase 4 |
| Recruiting | Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Ope NCT06313749 | Sanoculis Ltd | N/A |
| Terminated | An Extension Trial for Patients With Open-Angle Glaucoma Who Participated in the DF6-CL-20-01 Protocol. NCT06230393 | New World Medical, Inc. | — |
| Not Yet Recruiting | The A D A G I O Study NCT06455683 | Guy's and St Thomas' NHS Foundation Trust | — |
| Recruiting | A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Cli NCT06267274 | Amneal Pharmaceuticals, LLC | Phase 1 |
| Unknown | OCTA in Patients With Primary Open-angle Glaucoma NCT06214676 | Assiut University | — |
| Completed | Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution NCT05938699 | Nicox Ophthalmics, Inc. | Phase 2 / Phase 3 |
| Recruiting | A Study to Evaluate Adverse Events and Change in Disease Activity With the XEN45 Glaucoma Treatment System Imp NCT05821855 | AbbVie | Phase 4 |
| Recruiting | Comparative Effectiveness and Safety of ELIOS in Patients With Open-Angle Glaucoma Undergoing Cataract Surgery NCT06246136 | Elios Vision, Inc. | N/A |
| Unknown | Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular Hypertension NCT06152861 | Glaukos Corporation | Phase 2 |
| Active Not Recruiting | Travoprost Intraocular Implant in Conjunction With Cataract Surgery NCT06061718 | Glaukos Corporation | Phase 3 |
| Recruiting | Trabeculopuncture as Predictive Test for the Success of Ab Interno Trabeculectomy NCT06523751 | Wuerzburg University Hospital | N/A |
| Withdrawn | TF for the Prediction of Visual Field Progression NCT03047239 | Sensimed AG | N/A |
| Active Not Recruiting | A Study of PER-001 in Participants With Open-Angle Glaucoma NCT05822245 | Perfuse Therapeutics, Inc. | Phase 1 / Phase 2 |
| Unknown | Hydrus Microstent as a Quality of Life Consideration NCT05955118 | InSight Vision Center Medical Group, Inc | — |
| Completed | Minimally Invasive Nasal Trabeculostomy: Long-Term Follow-Up Extension Study NCT06612346 | Sanoculis Ltd | — |
| Recruiting | Inferonasal MIMS® Procedure: Long-Term Follow-Up Extension Study NCT06577857 | Sanoculis Ltd | — |
| Active Not Recruiting | Efficacy and Safety of Trabecular Meshwork Microstent Drainage System ( MicroCOGO ) NCT06741774 | Healthguard Biomed | N/A |
| Terminated | Efficacy of the Nanodropper Device on Intraocular Pressure in Patients With Glaucoma NCT05273385 | University of California, San Francisco | N/A |
| Terminated | Combined Phacoemulsification With iStent Inject W Versus Hydrus for Mild to Moderate Open Angle Glaucoma NCT05583591 | Diablo Eye Associates | N/A |
| Enrolling By Invitation | Study of the CycloPen Micro-Interventional System and Long-Term Clinical Outcomes NCT05506423 | Iantrek, Inc. | — |
| Unknown | A Study to Investigate the Effect of IOP-lowering With TO-O-1001 Eye Drops in Healthy Subjects and in Patients NCT05456724 | Theratocular Biotek Co. | Phase 1 / Phase 2 |
| Completed | Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (X NCT05411198 | AbbVie | Phase 3 |
| Recruiting | STAR-LIFE: a Post-market Registry on MINIject NCT05269680 | iSTAR Medical | — |
| Completed | A Phase 1b Study of ONL1204 Ophthalmic Solution in Patients with Progressing Open Angle Glaucoma NCT05160805 | ONL Therapeutics | Phase 1 |
| Unknown | Effect of Repeated Low-Level Red-Light Therapy on Visual Field Damage in Primary Open-angle Glaucoma NCT05309811 | Zhongshan Ophthalmic Center, Sun Yat-sen University | N/A |
| Completed | A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Ope NCT05335122 | Ocular Therapeutix, Inc. | Phase 2 |
| Completed | Study of a Latanoprost Ocular Implant for Treatment of Open Angle Glaucoma or Ocular Hypertension. NCT05333419 | PolyActiva Pty Ltd | Phase 1 |
| Active Not Recruiting | STREAMLINE®SURGICAL SYSTEM Compared to iStent Inject W® in Patients With Open-Angle Glaucoma NCT05280366 | New World Medical, Inc. | N/A |
| Terminated | Safety and Effectiveness of the Hydrus Microstent NCT05198297 | Alcon Research | N/A |
| Active Not Recruiting | Swedish Microinvasive Glaucoma Surgery Study (SMIGS) NCT05035394 | Umeå University | N/A |
| Unknown | PSLT Compared to Prostaglandin Analogue Eye Drops NCT05241938 | Federal University of Rio Grande do Sul | N/A |
| Completed | Nebivolol 0.5, 1.0, or Timolol 0.5 Suspension Compared to Timolol 0.5 Solution to Treat Glaucoma/Ocular Hypert NCT04910100 | Betaliq, Inc. | Phase 2 |
| Suspended | Safety and Efficacy Study of JV-GL1 in Patients With Open-Angle Glaucoma or Ocular Hypertension NCT04761705 | JeniVision, Inc. | Phase 1 / Phase 2 |
| Completed | A First in Human Clinical Trial to Evaluate the Safety and Effectiveness of the STREAMLINE SURGICAL SYSTEM in NCT05089474 | New World Medical, Inc. | N/A |
| Completed | 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) NCT04647214 | Allergan | — |
| Completed | The Effects of DSLT and SLT on the Corneal Endothelium: A GLAUrious Trial Sub-Study NCT04758598 | BelkinVision | N/A |
| Completed | A FIH Trial of the STREAMLINE™ SURGICAL SYSTEM NCT04700189 | New World Medical, Inc. | N/A |
| Completed | Study of Exchange of Travoprost Intraocular Implant NCT04615403 | Glaukos Corporation | Phase 2 |
| Recruiting | AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension NCT04499248 | AbbVie | Phase 1 / Phase 2 |
| Completed | MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension NCT04630808 | Nicox Ophthalmics, Inc. | Phase 3 |
| Unknown | A Single Center Proof Of Concept Study To Assess Intra And Perioperative Safety Profile Of OMNI Surgical Syste NCT04530084 | Mark Gallardo, MD | N/A |
| Recruiting | MINIject Global Long-Term Follow-up Study NCT04524416 | iSTAR Medical | — |
| Unknown | Effect of MEMOPTIC on Visual Field of Patients Followed for a Chronic Open-angle Glaucoma NCT04499157 | Centre Hospitalier Universitaire, Amiens | N/A |
| Completed | Computer-aided Diagnosis of Ocular Diseases Based on Corneal Biomechanics NCT04475900 | Technische Universität Dresden | — |
| Completed | A Phase 3b Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients Wit NCT04285580 | AbbVie | Phase 3 |
| Completed | Phase 3 Trial of NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension NCT04445519 | Nicox Ophthalmics, Inc. | Phase 3 |
| Completed | iCare® Home vs Goldmann Applanation Tonometry NCT04911387 | St. Erik Eye Hospital | — |
| Completed | Open Label, Sequential-dose Study of PA5108 Latanoprost FA SR Ocular Implant for Mild-moderate Glaucoma NCT04060758 | PolyActiva Pty Ltd | Phase 1 |
| Completed | Long-term Safety and Performance of the ARGOS-SC Suprachoroidal Pressure Sensor System in Patients With Glauco NCT04773106 | Implandata Ophthalmic Products GmbH | N/A |
| Completed | Correlation Between Optical Coherence Tomography Angiography and Photopic Negative Response in Patients With G NCT05104294 | Benha University | — |
| Withdrawn | IOP and Medication Reduction in MIGS Procedures NCT04202510 | Wills Eye | N/A |
| Withdrawn | African Glaucoma Laser Trial NCT03648229 | West Virginia University | Phase 4 |
| Completed | Reproducibility of Blood Flowmetry in Human Retina Using the Nidek Laser Speckle Flowgraphy LSFG-NAVI System NCT04014933 | University of Zurich | — |
| Withdrawn | A Comparative Study of SPARC's SDP-133 Once Daily and Lumigan in Subjects With Open Angle Glaucoma or Ocular H NCT03927443 | Sun Pharmaceutical Industries Limited | Phase 3 |
| Withdrawn | Pilocarpine After Combined Cataract/Trabectome Surgery NCT04005079 | Montefiore Medical Center | Phase 3 |
| Completed | Safety and Efficacy of Ophthalmic Phentolamine Mesylate in Glaucoma NCT03960866 | Ocuphire Pharma, Inc. | Phase 2 |
| Terminated | Comparing Preoperative Injection of Mitomycin-C vs. Intraoperative Injection of Mitomycin-C vs. Topical Applic NCT03875911 | University of California, Los Angeles | Phase 4 |
| Active Not Recruiting | Long-term Safety and Efficacy Extension Trial of Bimatoprost SR NCT03891446 | AbbVie | Phase 3 |
| Terminated | Standalone OMNI Surgical System for Open-angle Glaucoma NCT04427995 | Iqbal Ahmed | — |
| Completed | Efficacy and Systemic Safety of Netarsudil 0.01%, 0.02%, 0.04% Relative to Placebo in Subjects With Open-angle NCT03844945 | Aerie Pharmaceuticals | Phase 2 |
| Completed | Study of OMNI System in OAG (GEMINI) NCT03861169 | Sight Sciences, Inc. | N/A |
| Completed | Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hype NCT03850782 | AbbVie | Phase 3 |
| Completed | Performance and Safety of the ARGOS-SC Suprachoroidal Pressure Sensor in Patients With Glaucoma Undergoing Non NCT03756662 | Implandata Ophthalmic Products GmbH | N/A |
| Completed | A Study to Assess an Automated Laser Device for Direct Selective Laser Trabeculoplasty NCT03750201 | BelkinVision | N/A |
| Completed | Evaluation of Safety and Efficacy of PDP-716 NCT03450629 | Sun Pharma Advanced Research Company Limited | Phase 3 |
| Completed | Ologen® Collagen Matrix Versus Mitomycin-C in Patients With Juvenile-onset Open Angle Glaucoma NCT03548805 | L.V. Prasad Eye Institute | N/A |
| Completed | Study of ANX007 in Participants With Primary Open-angle Glaucoma NCT04188015 | Annexon, Inc. | Phase 1 |
| Completed | Safety and Tolerability of a Prostaglandin Ocular Implant for Treatment of Open Angle Glaucoma NCT03604328 | PolyActiva Pty Ltd | Phase 1 |
| Completed | Clinical Investigation of the eyeWatch Glaucoma Drainage Device NCT03210571 | Rheon Medical SA | N/A |
| Completed | CLN-0045: Safety, and Efficacy of OTX-TIC in Participants With Open Angle Glaucoma or Ocular Hypertension NCT04360174 | Ocular Therapeutix, Inc. | Phase 1 |
| Unknown | OMNI in Open-angle Glaucoma Treatment NCT04503356 | Centre of Postgraduate Medical Education | N/A |
| Completed | Single-dose Study of ANX007 in Participants With Primary Open-angle Glaucoma NCT03488550 | Annexon, Inc. | Phase 1 |
| Completed | Real World Evidence of Xen45 Gel Implant in Pseudoexfoliation Glaucoma NCT06993311 | Xerencia de Xestión Integrada de Ferrol | — |
| Completed | MINIject 636 in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications NCT03374553 | iSTAR Medical | N/A |
| Completed | Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GAN NCT03284853 | Aerie Pharmaceuticals | Phase 3 |
| Terminated | CoQun Study - (COQUN): a Study to Evaluate the Effects of CoQun in Patients Affected by Open-angle Glaucoma NCT03611530 | Mario Negri Institute for Pharmacological Research | N/A |
| Completed | Hydrus Microstent for Refractory Open-Angle Glaucoma NCT03267134 | Ivantis, Inc. | N/A |
| Withdrawn | Automatic vs. Manual Optic Disc Planimetry NCT02438319 | University of Zurich | — |
| Completed | MINIject in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications NCT03193736 | iSTAR Medical | N/A |
| Unknown | Changes in Choroidal Thickness After Non Penetrating Deep Sclerectomy NCT03160690 | Germans Trias i Pujol Hospital | — |
| Terminated | Safety and Effectiveness of the Sight Sciences VISCO™360 Versus SLT in Primary Open Angle Glaucoma NCT02928289 | Sight Sciences, Inc. | N/A |
| Completed | Phase 3 Study Evaluating Safety and Efficacy of OTX-TP in Subjects With OAG or OHT NCT02914509 | Ocular Therapeutix, Inc. | Phase 3 |
| Unknown | Different Glaucoma Treatments Effect on Intraocular Pressure Fluctuation With Postural Change in Eyes With Ope NCT02868502 | Meir Medical Center | — |
| Active Not Recruiting | STAR-LIFE Registry: STARflo Glaucoma Implant Clinical Experience Program NCT02825264 | iSTAR Medical | — |
| Completed | Nocturnal/Diurnal Intraocular Pressure-Lowering Effect of Netarsudil Ophthalmic Solution NCT02874846 | Aerie Pharmaceuticals | Phase 2 |
| Terminated | Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV® NCT02730871 | Alcon Research | Phase 4 |
| Completed | A Comparison of Two Ab Interno Procedures in the Treatment of Glaucoma in Patients Undergoing Cataract Extract NCT02784249 | New World Medical, Inc. | N/A |
| Completed | Subconjunctival Versus Direct Mitomycin C in Trabeculectomy NCT04352660 | University of California, San Diego | Phase 4 |
| Completed | A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle G NCT02742649 | ForSight Vision5, Inc. | Phase 1 / Phase 2 |
| Terminated | Safety and Efficacy of Anti-Oxidants and Anti-inflammatory Agents in Glaucoma and Diabetic Retinopathy NCT02984813 | The New York Eye & Ear Infirmary | Phase 1 |
| Completed | A Three Part Study of MGV354 in Ocular Hypertension or Glaucoma NCT02743780 | Alcon Research | Phase 1 / Phase 2 |
| Completed | Prevalence of Obstructive Sleep Apnoea in Glaucoma NCT02713152 | Papworth Hospital NHS Foundation Trust | — |
| Completed | Double-masked Study of PG324 Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension NCT02674854 | Aerie Pharmaceuticals | Phase 3 |
| Unknown | Efficacy and Safety of XEN® Gel Stent and Post-operative Management in Patients With Open Angle Glaucoma NCT03904381 | Wroclaw Medical University | Phase 4 |
| Completed | Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension NCT02558400 | Aerie Pharmaceuticals | Phase 3 |
| Completed | Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertens NCT02558374 | Aerie Pharmaceuticals | Phase 3 |
| Completed | SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA) NCT02419508 | Alcon Research | Phase 4 |
| Completed | Selective Laser Trabeculoplasty After Failed Phacoemulsification With Eximer Laser Trabeculectomy NCT02434250 | University of Zurich | N/A |
| Completed | Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimon NCT02339584 | Alcon Research | Phase 3 |
| Unknown | aICP in Glaucoma and Papilledema NCT02410148 | Kantonsspital Aarau | N/A |
| Completed | Efficacy and Safety Assessment of T2347 Versus Xalacom® in Ocular Hypertensive or Glaucomatous Patients NCT02278614 | Laboratoires Thea | Phase 3 |
| Completed | Comparison of Intraocular Pressure (IOP)-Lowering Efficacy and Safety of AZORGA® Ophthalmic Suspension and COS NCT02325518 | Alcon, a Novartis Company | Phase 4 |
| Completed | A Study of Simbrinza™ Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension NCT02348476 | Allergan | — |
| Withdrawn | The Effect of Omega-3 Fatty Acid Supplementation on Intraocular Pressure & Ocular Surface NCT02295358 | University of Colorado, Denver | — |
| Completed | SYL040012, Treatment for Open Angle Glaucoma NCT02250612 | Sylentis, S.A. | Phase 2 |
| Completed | 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma NCT02628223 | Temple University | N/A |
| Completed | STARflo European Safety and Efficacy Study NCT02272569 | iSTAR Medical | N/A |
| Completed | The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion Pressur NCT02165631 | University of Colorado, Denver | — |
| Completed | Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension NCT02207491 | Aerie Pharmaceuticals | Phase 3 |
| Completed | Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma and Ocular Hypertension NCT02207621 | Aerie Pharmaceuticals | Phase 3 |
| Completed | Multi-center Phase II Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With P NCT02179008 | Santen Inc. | Phase 2 |
| Completed | A 28 Day Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glauco NCT02083289 | Ono Pharmaceutical Co., Ltd. | Phase 2 |
| Completed | A Phase 1/2 Multicenter, Randomized, Study to Evaluate the Safety and Efficacy of VS101 Subconjunctival Latano NCT02129673 | ViSci Ltd. | Phase 1 / Phase 2 |
| Completed | Impact of Timolol/Dorzolamide Therapy on Autoregulation in Glaucoma Patients NCT02053298 | Universitaire Ziekenhuizen KU Leuven | Phase 4 |
| Completed | Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular Pressur NCT02057575 | Aerie Pharmaceuticals | Phase 2 |
| Completed | Efficacy of Travoprost/Timolol for Uncontrolled Intraocular Pressure NCT02003391 | Alcon Research | Phase 4 |
| Terminated | Prospective, Open Label Study to Assess 24hs IOP Recorded With Triggerfish® in Patients With OAG Before and Af NCT05876936 | University Hospital, Geneva | N/A |
| Completed | A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma NCT02014142 | Mati Therapeutics Inc. | Phase 2 |
| Completed | Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin Analogue NCT01937312 | Alcon Research | Phase 4 |
| Completed | Evaluation of Intraocular Pressure Using Simbrinza™ in Patients With Open-Angle Glaucoma or Ocular Hypertensio NCT01978600 | Alcon Research | Phase 4 |
| Terminated | TF (SENSIMED Triggerfish) in Intraocular Anti-VEGF (Vascular Endothelial Growth Factor) Injection NCT01983579 | Sensimed AG | Phase 4 |
| Completed | Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z® NCT01937299 | Alcon Research | Phase 4 |
| Completed | A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0. NCT01936389 | Robert Ritch, MD, LLC. | Phase 2 |
| Completed | Micropulse Laser Trabeculoplasty (MLT) Versus Selective Laser Trabeculoplasty (SLT) for Treatment of Open Angl NCT01956942 | David Belyea | N/A |
| Completed | The Expression of Matrix Metalloproteinase 13, Tissue Inhibitor of Metalloproteinases 3, and Calcium-sensing R NCT02638181 | Lv Yingjuan | N/A |
| Completed | Clinical Evaluation of Visco-Assisted CyPass® Micro-Stent Implantation in Patients With Open Angle Glaucoma NCT02448875 | Transcend Medical, Inc. | N/A |
| Completed | Two Trabecular Micro-bypass Stents & Postoperative Travoprost to Treat Glaucoma Subjects on Two Hypotensive Ag NCT02873806 | Glaukos Corporation | Phase 4 |
| Completed | Two Second-Generation Trabecular Micro-bypass Stents to Treat Glaucoma Subjects on One Hypotensive Medication NCT02868190 | Glaukos Corporation | Phase 4 |
| Completed | Ocular Blood Flow in Glaucoma Patients - the Leuven Eye Study NCT01840202 | Universitaire Ziekenhuizen KU Leuven | — |
| Completed | Micropulse Laser Trabeculoplasty (532nm) Versus Conventional Laser Trabeculoplasty (532nm) NCT01788319 | Universitaire Ziekenhuizen KU Leuven | N/A |
| Completed | Study on the Impact of Ocular Anesthetic Procedures in Ocular Blood Flow NCT01840215 | Universitaire Ziekenhuizen KU Leuven | — |
| Unknown | IOP Lowering Effect of PLT Versus SLT in Naiv OAG Patients NCT01886456 | University of Zurich | N/A |
| Completed | A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days NCT01789736 | Aerie Pharmaceuticals | Phase 2 |
| Completed | Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocu NCT01749904 | Bausch & Lomb Incorporated | Phase 3 |
| Completed | Study on Ocular Blood Flow and the Orbital Cerebrospinal Fluid Pressure in Glaucoma NCT01802463 | Universitaire Ziekenhuizen KU Leuven | — |
| Completed | Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution NCT01749930 | Bausch & Lomb Incorporated | Phase 3 |
| Unknown | Study on the Oxygen Saturation in Pulsating and Non-pulsating Central Retinal Veins NCT01794442 | Universitaire Ziekenhuizen KU Leuven | — |
| Terminated | A Study of Quantitative Assessments of Angle Width in Chinese Patients With Open-angle Glaucoma and/or Ocular NCT01781962 | Allergan | — |
| Withdrawn | Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OH NCT01721707 | Adapt Produtos Oftalmológicos Ltda. | Phase 3 |
| Completed | BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension NCT01707381 | Bausch & Lomb Incorporated | Phase 2 |
| Withdrawn | Prevalence of Dyschromatopsia in Glaucoma Patients NCT01994564 | Massachusetts Eye and Ear Infirmary | — |
| Completed | Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Press NCT01731002 | Aerie Pharmaceuticals | Phase 2 |
| Completed | A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular NCT01699464 | Aerie Pharmaceuticals | Phase 2 |
| Completed | Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in NCT01739244 | Sylentis, S.A. | Phase 2 |
| Completed | Safety of Hyaluronan Thiomer i.o. Implant During Combined Phacoemulsification - Non Penetrating Deep Sclerecto NCT01887873 | Croma-Pharma GmbH | Phase 1 |
| Completed | Diurnal and Nocturnal Effect of Travatan With SofZia Preservative on Intraocular Pressure and Ocular Perfusion NCT01779778 | University of Colorado, Denver | — |
| Completed | Study of AR-13324 in Patients With Elevated Intraocular Pressure NCT01528787 | Aerie Pharmaceuticals | Phase 2 |
| Completed | Efficacy and Safety of the ExPRESS Implant Versus Deep Sclerectomy in Combined Surgery NCT03201354 | Institut Catala de Retina | N/A |
| Completed | Efficacy of Changing to TRAVATAN® From Prior Therapy NCT01510145 | Alcon Research | Phase 4 |
| Withdrawn | Travacom Post Marketing Surveillance Study NCT01510132 | Alcon Research | Phase 4 |
| Completed | Efficacy of Changing to TRAVATAN® From Prior Therapy NCT01493427 | Alcon Research | Phase 4 |
| Completed | Comparison of Gonioscopy With Cirrus and Visante NCT01895686 | Wills Eye | — |
| Completed | Travoprost 3-Month Safety and Efficacy Study NCT01453855 | Alcon Research | Phase 3 |
| Withdrawn | Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004% NCT01452009 | Alcon Research | Phase 3 |
| Completed | Observational Study of Lumigan® 0.01% for Treatment of Primary Open Angle Glaucoma (POAG) or Ocular Hypertensi NCT01568008 | Allergan | — |
| Completed | Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension T NCT01464424 | Alcon Research | Phase 4 |
| Completed | Open-angle Glaucoma Subjects on One Topical Hypotensive Medication Randomized to Treatment With One or Two Tra NCT01455467 | Glaukos Corporation | N/A |
| Completed | Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Sur NCT01443988 | Glaukos Corporation | Phase 4 |
| Completed | Waveform Analysis of the Doppler Curve of Ophthalmic Arteries in Glaucoma Patients NCT01487655 | Universitaire Ziekenhuizen KU Leuven | — |
| Completed | Patient Preference Comparison of AZARGA Versus COSOPT NCT01340014 | Alcon Research | Phase 4 |
| Completed | Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada NCT01415401 | Alcon Research | Phase 4 |
| Completed | A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2% NCT01426867 | Alcon Research | Phase 2 |
| Completed | Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Sur NCT01444040 | Glaukos Corporation | Phase 4 |
| Completed | Open-Angle Glaucoma Subjects With One Prior Trabeculectomy Treated Concurrently With One Suprachoroidal Stent NCT01456390 | Glaukos Corporation | N/A |
| Completed | Open-angle Glaucoma Subjects on One Ocular Hypotensive Medication Randomized to Treatment With Two Trabecular NCT01444105 | Glaukos Corporation | N/A |
| Completed | Impact of a Tolerability Switch to Dorzolamide/Timolol Preservative-free Fixed Combination on Ocular Surface S NCT01923714 | Universitaire Ziekenhuizen KU Leuven | — |
| Completed | Efficacy of Changing to DUOTRAV® From Prior Therapy NCT01327599 | Alcon Research | Phase 4 |
| Terminated | Safety and Intraocular Pressure (IOP) Lowering Effect of AL-59412C NCT01312454 | Alcon Research | Phase 2 |
| Completed | 24-hour Efficacy of AR-12286 NCT01330979 | Aerie Pharmaceuticals | Phase 2 |
| Completed | Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in NCT01309204 | Alcon Research | Phase 3 |
| Completed | DE-111 Against Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solut NCT01342081 | Santen Pharmaceutical Co., Ltd. | Phase 3 |
| Completed | Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in P NCT01310777 | Alcon Research | Phase 3 |
| Completed | DE-111 Against Timolol Ophthalmic Solution 0.5% NCT01342094 | Santen Pharmaceutical Co., Ltd. | Phase 3 |
| Completed | Tafluprost-Timolol Fixed Dose Combination Non-Inferiority Study Against Concomitant Administrations NCT01306461 | Santen Oy | Phase 3 |
| Completed | Three Month Efficacy/Safety Study With a 3-Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brin NCT01297920 | Alcon Research | Phase 3 |
| Completed | Intraocular Pressure, Blood Pressure, Ocular Perfusion and Blood Flow Fluctuations in Glaucoma Patients NCT01304264 | Lithuanian University of Health Sciences | — |
| Completed | Tafluprost-Timolol Preservative-free Fixed Dose Combination (FDC) Superiority Study Against Monotherapies NCT01292460 | Santen Oy | Phase 3 |
| Completed | Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2% NCT01297517 | Alcon Research | Phase 3 |
| Completed | Comparative Effectiveness of Treatment Strategies for Primary Open-Angle Glaucoma NCT01645319 | Agency for Healthcare Research and Quality (AHRQ) | — |
| Completed | Divided Dose of TRAVATAN® NCT01298687 | Alcon Research | Phase 2 |
| Unknown | Safety and Efficacy of Canaloplasty and Non-penetrating Deep Sclerectomy With Phacoemulsification to Treat Gla NCT01726543 | Military Institute od Medicine National Research Institute | N/A |
| Completed | Validation of Retinal Oximetry in Glaucoma Patients: a Structural and Functional Correlation NCT01391247 | Universitaire Ziekenhuizen KU Leuven | — |
| Completed | Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension NCT01279083 | Santen Inc. | Phase 1 / Phase 2 |
| Completed | Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or NCT01357616 | Alcon Research | Phase 3 |
| Completed | Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular Hypertension NCT00945958 | Sun Pharma Advanced Research Company Limited | Phase 3 |
| Completed | A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension NCT01229982 | Mati Therapeutics Inc. | Phase 2 |
| Completed | Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Oc NCT01157364 | Allergan | Phase 1 / Phase 2 |
| Completed | Effects of Selective Laser Trabeculoplasty on Aqueous Humor Dynamics NCT01342406 | University of Nebraska | — |
| Completed | The Effects of Preservative-free Prostaglandin Eye Drops in Sign and Symptoms on the Eyes of Patients With Gla NCT01369771 | FinnMedi Oy | Phase 4 |
| Completed | Surgical Treatment of Refractory Open Angle Glaucoma NCT01212861 | iScience Interventional Corporation | N/A |
| Completed | Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular Hypertension NCT00947661 | Sun Pharma Advanced Research Company Limited | Phase 3 |
| Completed | Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost to Preservative Free Tafluprost Eye D NCT01087671 | Santen Oy | Phase 3 |
| Unknown | Evaluation of OT-135P (IOPtiMateTM) : Beam Manipulating System for CO2 Laser Assisted Non-Penetrating Glaucoma NCT01059162 | IOPtima Ltd. | N/A |
| Terminated | DuoTrav APS Versus XALACOM® in Ocular Surface Health NCT00912054 | Alcon Research | Phase 3 |
| Completed | ELAZOP Switching Study in Korea NCT01055366 | Alcon Research | Phase 4 |
| Completed | Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular NCT01068964 | Allergan | N/A |
| Completed | Preservative-Free MK2452 (Tafluprost) for Open-Angle Glaucoma/Ocular Hypertension (MK2452-001)(COMPLETED) NCT01026831 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma NCT00872651 | Alcon Research | Phase 3 |
| Completed | A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG NCT01037036 | Mati Therapeutics Inc. | Phase 2 |
| Terminated | Trabectome Versus Trabeculectomy With Mitomycin C in Patients With Open Angle Glaucoma NCT00901108 | University of Alberta | Phase 3 |
| Unknown | Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Trabeculectomy: A Study in Germany NCT01174420 | Aeon Astron Europe B.V. | N/A |
| Completed | Safety and Efficacy of a Drug Delivery System in Glaucoma NCT01016691 | Vistakon Pharmaceuticals | Phase 2 |
| Terminated | Safety and Efficacy of Brinzolamide/Brimonidine Fixed Combination NCT00961649 | Alcon Research | Phase 2 |
| Completed | Central Corneal Thickness and 24-hour Fluctuation of Intraocular Pressure NCT00941525 | Aristotle University Of Thessaloniki | Phase 4 |
| Completed | Safety and Intraocular Pressure (IOP)-Lowering Efficacy of AL-39256 in Patients With Open-Angle Glaucoma or Oc NCT00761709 | Alcon Research | Phase 2 |
| Completed | Safety Study of DuoTrav APS in Patients With Open-Angle Glaucoma or Ocular Hypertension NCT00928590 | Alcon Research | Phase 3 |
| Unknown | Goniocurettage as First Choice of Surgical Treatment in Chronic Open-Angle Glaucoma: Outcomes and Complication NCT01511094 | Federal University of Minas Gerais | Phase 2 / Phase 3 |
| Completed | Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface Health NCT00892762 | Alcon Research | Phase 3 |
| Unknown | Near to Infrared (NIR) Light Neuroprotection in Glaucomatous Optic Neuropathy NCT00844389 | Universidad de Valparaiso | EARLY_Phase 1 |
| Completed | Equivalence Study of Dorzolamide 2% Eye Drops Solution NCT00878917 | Alfred E. Tiefenbacher (GmbH & Co. KG) | Phase 3 |
| Completed | Efficacy Study of Travoprost APS Versus TRAVATAN NCT00848536 | Alcon Research | Phase 3 |
| Withdrawn | Safety and Efficacy Study of DuoTrav APS Versus DuoTrav NCT00862472 | Alcon Research | Phase 3 |
| Completed | Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension NCT00868894 | Santen Inc. | Phase 1 / Phase 2 |
| Completed | DuoTrav® Eye Drops As Replacement Therapy Program NCT00828906 | Alcon Research | Phase 4 |
| Completed | A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs NCT00823043 | Vistakon Pharmaceuticals | — |
| Completed | A 12 Week Comparison of DuoTrav and Xalacom in Open-Angle Glaucoma NCT00887029 | Ophthalmic Consultants Centres, Canada | Phase 4 |
| Completed | A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS) NCT00821002 | Mati Therapeutics Inc. | Phase 2 |
| Withdrawn | The Effects of Cosopt® Vs Xalacom® on Ocular Hemodynamics and Intraocular Pressure (IOP) in Primary Open-angle NCT00815373 | Meir Medical Center | N/A |
| Terminated | A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension NCT00788541 | Alcon Research | Phase 2 |
| Completed | Examination of Ocular Surface Effects With Administration of Travatan Z and XALATAN NCT00798759 | Alcon Research | Phase 4 |
| Completed | Phase III Clinical Trial of TRAVATAN Z in Ocular Surface Health NCT00761319 | Alcon Research | Phase 3 |
| Completed | Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Comb NCT00759239 | Alcon Research | Phase 4 |
| Completed | Travatan Z in Ocular Surface Health in Patients With Open-Angle Glaucoma or Ocular Hypertension NCT00690794 | Alcon Research | Phase 3 |
| Completed | Safety and Efficacy of Travoprost/Timolol BAC-free NCT00760539 | Alcon Research | Phase 3 |
| Completed | Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension NCT00691717 | Alcon Research | Phase 2 / Phase 3 |
| Completed | Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate NCT00698945 | Bp Consulting, Inc | Phase 4 |
| Withdrawn | A Multi-Dose Study With a Treatment for Open-Angle Glaucoma NCT00705770 | Alcon Research | Phase 2 / Phase 3 |
| Completed | A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertensio NCT00672997 | Alcon Research | Phase 3 |
| Completed | Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular Hypertension NCT00670033 | Alcon Research | Phase 2 |
| Completed | Dry Eye and Irritation Comparison of Latanoprost With the Preservative Versus Travoprost Without Preservative NCT00803387 | United States Air Force | — |
| Completed | Evaluation of Pascal Laser Trabeculoplaty NCT00838721 | Santa Clara Valley Health & Hospital System | N/A |
| Completed | Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension NCT00650338 | Santen Inc. | Phase 2 |
| Completed | Collection of Blood Specimens From Patients in AL-3789 Studies for Elevated Intraocular Pressure (IOP) NCT00691639 | Alcon Research | — |
| Completed | 24 Hour IOP Lowering Efficacy of AL-3789 NCT00643669 | Alcon Research | Phase 2 |
| Completed | Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost 0.005% to Preservative Free Taflupros NCT00596791 | Santen Oy | Phase 3 |
| Terminated | PASCAL Trabeculoplasty NCT00804323 | Asociación para Evitar la Ceguera en México | N/A |
| Completed | Adjunctive Study of AL-37807 Ophthalmic Suspension NCT00620256 | Alcon Research | Phase 2 |
| Completed | Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost NCT00637130 | Alcon Research | Phase 2 |
| Completed | Adherence Assessment With Travalert Dosing Aid NCT00508469 | Alcon Research | Phase 4 |
| Completed | Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues NCT00539526 | Allergan | Phase 4 |
| Completed | IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open NCT00527501 | Alcon Research | Phase 2 |
| Completed | Oculusgen (Ologen) Glaucoma MMC Control in Estonia NCT00524758 | Pro Top & Mediking Company Limited | Phase 3 |
| Completed | Ologen Collagen Matrix Safety and Effective Comparison With Mitomycin-C(MMC) in Glaucoma Surgery NCT00538590 | Pro Top & Mediking Company Limited | Phase 4 |
| Completed | Dry Eye Study With Cosopt® Over 8 Weeks in Patients With Open-Angle Glaucoma or Ocular Hypertension (0507A-152 NCT00545064 | Merck Sharp & Dohme LLC | Phase 4 |
| Completed | A Single Dose Comfort Comparison of Travatan Z in One Eye Versus Xalatan in the Opposite Eye in Patients With NCT00527592 | Alcon Research | Phase 4 |
| Terminated | Comparing Acular LS and Pred Forte in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and NCT00478036 | University of Colorado, Denver | N/A |
| Withdrawn | Progressive Open Angle Glaucoma (OAG) and Ocular Blood Flow NCT00912470 | Medical University of Vienna | N/A |
| Completed | Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertensio NCT00465621 | Alcon Research | Phase 2 |
| Completed | Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma NCT00443924 | Merck Sharp & Dohme LLC | Phase 1 |
| Terminated | Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension NCT00471068 | Alcon Research | Phase 4 |
| Completed | Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma NCT00451152 | Alcon Research | Phase 2 |
| Completed | Safety and Efficacy of the GTS400 Stent in Conjunction With Cataract NCT00721968 | Glaukos Corporation | Phase 3 |
| Completed | A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension NCT00465803 | Alcon Research | Phase 3 |
| Completed | A Investigator Masked Parallel Comparison of Tolerability of Combigan and Cosopt NCT00621335 | DBYAN Medicine Professional Corporation | — |
| Completed | Does the Optic Disc Grading Done Visually by Your Doctor Agree With Optic Nerve Testing Which is Done by Machi NCT00430287 | Wills Eye | — |
| Completed | 24-hour IOP-lowering Effect of Brimonidine 0.1% NCT00457795 | Allergan | Phase 4 |
| Unknown | Comparison of Efficacy of Two Groups of Glaucoma Drops (Xalatan vs.Cosopt) in Reducing Eye Pressure Following NCT00440336 | Advanced Glaucoma Specialists | N/A |
| Completed | 24-hour Study of Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combinations NCT00397241 | Aristotle University Of Thessaloniki | Phase 4 |
| Completed | Determinants of Compliance With Glaucoma Therapy NCT01484392 | Legacy Health System | — |
| Completed | A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension NCT00326092 | Alcon Research | Phase 2 |
| Completed | A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension NCT00372931 | Alcon Research | Phase 2 |
| Completed | Anecortave Acetate in Patients With Open-angle Glaucoma NCT00320203 | Alcon Research | Phase 2 |
| Completed | Diurnal Intraocular Pressure and Peripapillary Retinal Blood Flow in Medically Controlled Open-Angle Glaucoma NCT00481208 | Yonsei University | — |
| Unknown | Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves and Second Trabeculectomy in Glaucoma Patients NCT00665756 | Federal University of São Paulo | N/A |
| Completed | A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension NCT00293761 | Alcon Research | Phase 3 |
| Completed | Lumigan Versus Cosopt NCT00273455 | Pharmaceutical Research Network | Phase 4 |
| Completed | A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects Wit NCT00277498 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 3 |
| Completed | A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension NCT00287521 | Alcon Research | Phase 2 |
| Completed | Assessing Cosopt Switch Patients NCT00273442 | Pharmaceutical Research Network | Phase 4 |
| Completed | A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension NCT00314158 | Alcon Research | Phase 3 |
| Completed | A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension NCT00314171 | Alcon Research | Phase 3 |
| Completed | Determinants of Compliance With Glaucoma Therapy NCT00362622 | University of Alabama at Birmingham | — |
| Completed | Cosopt Versus Xalacom NCT00273481 | Pharmaceutical Research Network | Phase 4 |
| Completed | Pharmacodynamics of Tafluprost 0.0015% Eye Drops: a Comparison Between the Preserved and Unpreserved Formulati NCT00918346 | Santen Oy | Phase 3 |
| Completed | A Study of the Trabecular Micro-bypass Stent in Combination With Cataract Surgery in Subjects With Open Angle NCT00323284 | Glaukos Corporation | Phase 3 |
| Completed | Latanoprost Versus Fotil NCT00304785 | Pharmaceutical Research Network | Phase 4 |
| Completed | Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angl NCT00822055 | Allergan | Phase 4 |
| Completed | Cosopt Versus Xalatan NCT00273429 | Pharmaceutical Research Network | Phase 4 |
| Completed | A Study of the iStent in Combo With Cataract Surgery in Newly Diagnosed Open Angle Glaucoma or OH Patients. NCT00326066 | Glaukos Corporation | N/A |
| Completed | Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angl NCT00822081 | Bp Consulting, Inc | Phase 4 |
| Completed | Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertensi NCT00288951 | Alcon Research | Phase 3 |
| Completed | Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pr NCT00716742 | Allergan | — |
| Unknown | A Study of the Glaukos Trabecular Micro-bypass Stent in Open Angle Glaucoma Subjects 1 Stent Versus 2 NCT00326079 | Glaukos Corporation | Phase 4 |
| Terminated | A Multicenter Study of the Pigmentation in the Trabecular Meshwork After Two Years of Treatment With TRAVATAN NCT01485822 | Alcon Research | — |